The increase of BRI2 in early stages of Alzheimer's disease correlates with reduced levels of ADAM10 and may prevent its binding to APP

✍ Scribed by Del Campo Milan, Marta; Hoozemans, Jeroen; Korth, Carsten; Müller-Schiffmann, Andreas; Scheltens, Philip; Blankenstein, Marinus A.; Jiménez, Connie; Veerhuis, Rob; Teunissen, Charlotte

• Book ID: 123459450
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 55 KB
• Volume: 9
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2013.05.1136